Biblio

Export 2878 results:
Author Keyword Title Type [ Year(Asc)]
2021
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., “Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
R. Squitti, Faller, P., Hureau, C., Granzotto, A., White, A. R., and Kepp, K. P., “Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.”, J Alzheimers Dis, vol. 83, no. 1, pp. 23-41, 2021.
A. Subotic, McCreary, C. R., Saad, F., Nguyen, A., Alvarez-Veronesi, A., Zwiers, A. M., Charlton, A., Beaudin, A. E., Ismail, Z., G Pike, B., and Smith, E. E., “Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1663-1671, 2021.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., “A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., “Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
P. Alexopoulos, Soldatos, R., Kontogianni, E., Frouda, M., Aligianni, S. Loanna, Skondra, M., Passa, M., Konstantopoulou, G., Stamouli, E., Katirtzoglou, E., Politis, A., Economou, P., Alexaki, M., Siarkos, K., and Politis, A., “COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder.”, J Alzheimers Dis, vol. 79, no. 1, pp. 459-466, 2021.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., “Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., “Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
M. Waller, Buckley, R. F., Masters, C. L., Nona, F. R., Eades, S., and Dobson, A. J., “Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
E. Fuller-Thomson and Ahlin, K. Marie, “A Decade of Decline in Serious Cognitive Problems Among Older Americans: A Population-Based Study of 5.4 Million Respondents.”, J Alzheimers Dis, vol. 85, no. 1, pp. 141-151, 2021.
J. C. de la Torre, “Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1381-1396, 2021.
S. Toniolo, Scarioni, M., Di Lorenzo, F., Hort, J., Georges, J., Tomic, S., Nobili, F., and Frederiksen, K. Steen, “Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.”, J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
J. J. S. Rutten, van Kooten, J., van Loon, A. M., van Buul, L. W., Joling, K. J., Smalbrugge, M., and Hertogh, C. M. P. M., “Dementia and Parkinson's Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19.”, J Alzheimers Dis, vol. 84, no. 3, pp. 1173-1181, 2021.
N. L. Olson and Albensi, B. C., “Dementia-Friendly "Design": Impact on COVID-19 Death Rates in Long-Term Care Facilities Around the World.”, J Alzheimers Dis, vol. 81, no. 2, pp. 427-450, 2021.
L. Gerritsen, Twait, E. L., Jonsson, P. V., Gudnason, V., Launer, L. J., and Geerlings, M. I., “Depression and Dementia: The Role of Cortisol and Vascular Brain Lesions. AGES-Reykjavik Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1677-1687, 2021.
W. D. Brenowitz, Hazzouri, A. Zeki Al, Vittinghoff, E., Golden, S. H., Fitzpatrick, A. L., and Yaffe, K., “Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1379-1389, 2021.
K. N. Devlin, Brennan, L., Saad, L., Giovannetti, T., Hamilton, R. H., Wolk, D. A., Xie, S. X., and Mechanic-Hamilton, D., “Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods.”, J Alzheimers Dis, vol. 85, no. 2, pp. 627-644, 2021.
S. Gauci, Young, L. M., White, D. J., Reddan, J. M., Lassemillante, A. - C., Meyer, D., Pipingas, A., and Scholey, A., “Diet May Moderate the Relationship Between Arterial Stiffness and Cognitive Performance in Older Adults.”, J Alzheimers Dis, vol. 85, no. 2, pp. 815-828, 2021.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., “Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
W. J. Streit, Rotter, J., Winter, K., Müller, W., Khoshbouei, H., and Bechmann, I., “Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1701-1720, 2021.
S. Ikeda, Mimura, M., Ikeda, M., Wada-Isoe, K., Azuma, M., Inoue, S., and Tomita, K., “Economic Burden of Alzheimer's Disease Dementia in Japan.”, J Alzheimers Dis, vol. 81, no. 1, pp. 309-319, 2021.
N. Soldevila-Domenech, Forcano, L., Boronat, A., Lorenzo, T., Piera, I., Puig-Pijoan, A., Mateus, J., Gómez, J. María Gon, Knezevic, I., Soteras, A., Fauria, K., Pizarro, N., Molinuevo, J. Luis, and de la Torre, R., “Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1015-1021, 2021.
K. Lengu, Ryan, S., Peltier, S. J., Tyszkowski, T., Kairys, A., Giordani, B., and Hampstead, B. M., “Effects of High Definition-Transcranial Direct Current Stimulation on Local GABA and Glutamate Levels Among Older Adults with and without Mild Cognitive Impairment: An Exploratory Study.”, J Alzheimers Dis, vol. 84, no. 3, pp. 1091-1102, 2021.
A. Tofiq, Zetterberg, H., Blennow, K., Basun, H., Cederholm, T., Eriksdotter, M., Faxen-Irving, G., Hjorth, E., Jernerén, F., Schultzberg, M., Wahlund, L. - O., Palmblad, J., and Freund-Levi, Y., “Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1291-1301, 2021.

Pages